Minocycline Hydrochloride Patent Expiration

Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc in its drug Minocin on Approved Prior to Jan 1, 1982. Other drugs containing Minocycline Hydrochloride are Minolira, Emrosi, Arestin, Solodyn, Zilxi, Minocycline Hydrochloride, Amzeeq, Ximino. 31 different companies have introduced drugs containing Minocycline Hydrochloride.


Minocycline Hydrochloride Patents

Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Emrosi US10905664 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Emrosi US11191740 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Emrosi US11364212 Methods for treating inflammatory skin conditions Jan 07, 2039 Journey
Amzeeq US10398641 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Amzeeq US10849847 Compositions and methods for treating rosacea and acne Sep 08, 2037 Journey
Minolira US11103517 Pharmaceutical compositions for minocycline Apr 07, 2036 Epi Hlth
Minocin US11944634 Tetracycline compositions Oct 16, 2032 Rempex
Solodyn US9192615 Method for the treatment of acne and certain dosage forms thereof Nov 17, 2031 Bausch
Minocin US12161656 Tetracycline compositions May 12, 2031 Rempex
Minocin US9084802 Tetracycline compositions May 12, 2031 Rempex
Minocin US9278105 Tetracycline compositions May 12, 2031 Rempex
Amzeeq US10086080 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10137200 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US10517882 Method for healing of an infected acne lesion without scarring Oct 01, 2030 Journey
Amzeeq US10821187 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Amzeeq US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Amzeeq US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Amzeeq US9675700 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10213512 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10265404 Compositions, gels and foams with rheology modulators and uses thereof Oct 01, 2030 Journey
Zilxi US10322186 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US10946101 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US12138311 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US8865139 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct 01, 2030 Journey
Zilxi US8992896 Topical tetracycline compositions Oct 01, 2030 Journey
Zilxi US9675700 Topical tetracycline compositions Oct 01, 2030 Journey
Solodyn US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Solodyn US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Bausch
Ximino US7541347 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Ximino US7544373 Minocycline oral dosage forms for the treatment of acne Apr 02, 2027 Journey
Solodyn US7919483 Method for the treatment of acne Mar 07, 2027 Bausch
Ximino US7919483 Method for the treatment of acne Mar 07, 2027 Journey
Solodyn US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Bausch
Solodyn US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Bausch
Solodyn US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Bausch
Solodyn US8722650 Extended-release minocycline dosage forms Jun 24, 2025

(Expired)

Bausch
Ximino US7790705 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Journey
Ximino US8252776 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Journey
Ximino US8268804 Minocycline oral dosage forms for the treatment of acne Jun 24, 2025

(Expired)

Journey
Arestin US6682348 Dispensing apparatus and cartridge Mar 29, 2022

(Expired)

Orapharma
Arestin US7699609 Dispensing apparatus and cartridge with deformable tip Mar 29, 2022

(Expired)

Orapharma
Solodyn US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

Bausch
Ximino US5908838 Method for the treatment of acne Feb 19, 2018

(Expired)

Journey



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Minocycline Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Minocycline Hydrochloride.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 20 Feb, 2024 US8268804(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Jan, 2024 US8252776(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 20 Apr, 2023 US9192615
Payment of Maintenance Fee, 4th Yr, Small Entity 19 Dec, 2022 US10322186
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2022 US7919483(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 23 Feb, 2022 US7790705(Litigated)
Recordation of Patent Grant Mailed 16 Mar, 2021 US10946101
Patent Issue Date Used in PTA Calculation 16 Mar, 2021 US10946101
Email Notification 26 Feb, 2021 US10946101
Issue Notification Mailed 24 Feb, 2021 US10946101


Minocycline Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Minocycline Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Minocycline Hydrochloride. The first generic version for Minocycline Hydrochloride was by Lederle Laboratories Div American Cyanamid Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Nexus Pharmaceuticals Llc and was approved on Oct 24, 2024.

Given below is the list of companies who have filed for Minocycline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.